SYKStryker Corporation

$277.28-26% 1Y

Is it growing?

Good

Growing: earnings up +28% year on year and operating margin widening (+5.8 points).

2 good, 1 neutral
Revenue trend+8% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +10% a year.

Earnings trend+28% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+5.8 points operating

Trailing-twelve-month operating margin, 21.2% now against 15.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 66% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is SYK growing?

Stryker Corporation has grown revenue 9.9% a year over three years and 9.7% a year over five, with earnings per share compounding at 11%.

+9.9%

Revenue growth, 3-year annual rate · Medical Devices median +12% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+9.7%

Revenue growth, 5-year rate · +9.9% over three · growth has picked up over the last three years

Earnings per share, 3-year rate
+11%

Earnings per share, 3-year rate · revenue +9.9% · earnings outgrew revenue: margins or the share count worked for shareholders

Years of annual history on file
19

Years of annual history on file · FY2007 to FY2025, as filed

Details›
Revenue FY2021
$17.1B
Revenue FY2022
$18.4B
Revenue FY2023
$20.5B
Revenue FY2024
$22.6B
Revenue FY2025
$25.1B

Annual income statements as filed with the SEC.